BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 13847797)

  • 1. [Influence of subcutaneously and intramuscularly administered zymosan on the properdin titer of serum and on leukocyte count in animal experiments].
    ZSEBOK Z; WACHTL I; SZY S; SELLEI G
    Orv Hetil; 1960 Feb; 101():226-9. PubMed ID: 13847797
    [No Abstract]   [Full Text] [Related]  

  • 2. [Experimental studies and therapeutic experiences on the radiation protection effect of subcutaneously and intramuscularly administered zymosan].
    NAGY S; CSAKY G; CSEH G; KOSZORU M
    Radiobiol Radiother (Berl); 1961; 2():129-34. PubMed ID: 14477979
    [No Abstract]   [Full Text] [Related]  

  • 3. [Influencing of the serum properdin levels of patients with neoplasms by parenteral administration of zymosan].
    SZABO IK
    Orv Hetil; 1960 Feb; 101():222-5. PubMed ID: 13836258
    [No Abstract]   [Full Text] [Related]  

  • 4. The properdin system and immunity. XV. Some biologic effects of the administration of zvmosan and other polvsaccharides to rabbits, and the presence of antibodies to zymosan in human and rabbit serum.
    HINZ CF; WEDGWOOD RJ; PILLEMER L
    J Lab Clin Med; 1961 Feb; 57():185-98. PubMed ID: 13714488
    [No Abstract]   [Full Text] [Related]  

  • 5. [On the problem of the method of determination of properdin in human serum by the zymosan method].
    MASHKOV AV; MIKHAILOVA ZM
    Zh Mikrobiol Epidemiol Immunobiol; 1962 May; 33():103-8. PubMed ID: 14470783
    [No Abstract]   [Full Text] [Related]  

  • 6. [Interrelations of zymosan, properdin & tumors. III. Behavior of the properdin level in benzopyrene sarcoma-bearing rats treated with zymosan].
    FUMAROLA D; MODICA F
    Tumori; 1959; 45(1):46-53. PubMed ID: 13659609
    [No Abstract]   [Full Text] [Related]  

  • 7. Anaphylactic shock in zymosan pre-treated guinea-pigs. (A study on the possible role of properdin)].
    WILHELM RE; SALVAGGIO J; KRUPP I
    Int Arch Allergy Appl Immunol; 1961; 18():318-29. PubMed ID: 13831364
    [No Abstract]   [Full Text] [Related]  

  • 8. [Properdin system and its role in infection and immunity. II. Determination of biological activities of zymosan].
    ANDREEVA ZM; NIKITINA VD
    Zh Mikrobiol Epidemiol Immunobiol; 1960 Nov; 31():49-53. PubMed ID: 13683406
    [No Abstract]   [Full Text] [Related]  

  • 9. SOME RES EFFECTS INFLUENCING RADIATION SURVIVAL TIME.
    SZANTO A
    Acta Unio Int Contra Cancrum; 1964; 20():1233-5. PubMed ID: 14274743
    [No Abstract]   [Full Text] [Related]  

  • 10. The possible role of the properdin system in transplantable cancer; the effect of zymosan on transplantable human carcinoma.
    HERBUT PA; KRAEMER WH
    Cancer Res; 1956 Dec; 16(11):1048-52. PubMed ID: 13383472
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relation between zymosan, properdin & tumors. I. Effect of zymosan on the development of benzpyrene-induced sarcomas].
    MODICA F
    Tumori; 1958; 44(6):538-48. PubMed ID: 13635872
    [No Abstract]   [Full Text] [Related]  

  • 12. [The usefulness of various zymosan preparations in determination of properdin].
    von GRAEVENITZ ; HUSMANN KH; HOEBBEL K
    Med Exp Int J Exp Med; 1960; 3():230-6. PubMed ID: 13707673
    [No Abstract]   [Full Text] [Related]  

  • 13. Quantitative studies on the properdin-complement system. II. Kinetics of the reaction between properdin and zymosan.
    LEON MA
    J Exp Med; 1957 May; 105(5):403-15. PubMed ID: 13428911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of properdin levels in mice following administration of bacterial lipopolysaccharides.
    LANDY M; PILLEMER L
    J Exp Med; 1956 Jun; 103(6):823-33. PubMed ID: 13319594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On the influence of properdin inactivation on the radiation syndrome].
    ZSEBOK Z
    Strahlentherapie; 1959; 109():523-32. PubMed ID: 13847800
    [No Abstract]   [Full Text] [Related]  

  • 16. EVIDENCE FOR IMMUNOLOGICAL SPECIFICITY OF THE PROPERDIN SYSTEM; DEMONSTRATION, ISOLATION AND PROPERTIES OF A SERUM FACTOR WHICH INTERACTS WITH ZYMOSAN AND OTHER POLYSACCHARIDES AT 0 DEGREES CENTIGRADE.
    BLUM L
    J Immunol; 1964 Jan; 92():61-72. PubMed ID: 14139548
    [No Abstract]   [Full Text] [Related]  

  • 17. Alterations in serum lysozyme and properdin titers of mice following x-irradiation or treatment with zymosan or endotoxin.
    HOOK WA; CAREY WF; MUSCHEL LH
    J Immunol; 1960 Jun; 84():569-75. PubMed ID: 14402997
    [No Abstract]   [Full Text] [Related]  

  • 18. [THE ROLE OF THE PROPERDIN SYSTEM IN NON-SPECIFIC IMMUNITY].
    HOSHINO A
    Nihon Naika Gakkai Zasshi; 1963 Dec; 52():1023-40. PubMed ID: 14158037
    [No Abstract]   [Full Text] [Related]  

  • 19. [On the possibility of determination of blood properdin by means of zymosan in the serums of different animal species].
    MAZZEI D; TASCHINI P
    Policlinico Med; 1959; 66():391-401. PubMed ID: 13853881
    [No Abstract]   [Full Text] [Related]  

  • 20. The properdin system and immunity. XI. Studies on the interaction of zymosan with the properdin system.
    BLUM L; PILLEMER L; LEPOW IH
    Z Immun exp ther; 1959; 118():313-28. PubMed ID: 13801695
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.